SANGANI (SANGANI) fundamentals

SANGANI is a listed company, part of the Healthcare Services sector, listed on the NSE as SANGANI (ISIN INE0OVI01010). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.

What SANGANI does

Sangani Hospitals Limited is an India-based company, which is a multi-specialty healthcare provider operating in Keshod and Veraval regions of Gujarat. The Company’s services include specialty services in hospitals, and it also operates a pathology laboratory and medical stores. The Company operates approximately two hospitals, which are Sangani Hospital at Keshod, Junagadh, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. Sangani Hospital consists of approximately 36 bed multi-specialty hospital with primary, secondary, and tertiary care facilities. Sangani Super Speciality Hospital consists of approximately 32 bed multi-specialty hospital with a significant focus on tertiary care facilities. Both the hospitals offer a comprehensive range of healthcare services in specialties and super specialties, including cardiac sciences, neurosciences, orthopedics, renal sciences and mother and childcare.

Valuation and market data

Last close₹53.90
Market capitalisation₹74 crore
Enterprise value₹57 crore
P/E (TTM)6.46
Price to book2.06
Price to sales (TTM)1.29
Book value per share₹26.22
Dividend yield0.00%
SectorHealthcare Services
Industry

Annual results

PeriodRevenueProfit before taxNet profitEPS
Mar 2026₹108 crore₹8 crore₹6 crore0.00
Mar 2025₹23 crore₹3 crore₹3 crore1.88
Mar 2024₹17 crore₹4 crore₹3 crore2.17
Mar 2023₹16 crore₹2 crore₹2 crore1.62
Mar 2022₹4 crore₹1 crore₹1 crore2.67

Figures are as reported (consolidated), in ₹ crore.

Shareholding pattern

As of Jun 2026:

Promoters74.1%
Foreign institutions (FII)0.0%
Mutual funds0.0%
Other domestic institutions0.0%
Retail and others25.9%

More on BreakPoint

FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.

Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.